These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
134 related items for PubMed ID: 11351044
1. Metastatic behavior of human breast carcinomas overexpressing the Bcl-x(L) gene: a role in dormancy and organospecificity. Rubio N, España L, Fernández Y, Blanco J, Sierra A. Lab Invest; 2001 May; 81(5):725-34. PubMed ID: 11351044 [Abstract] [Full Text] [Related]
2. Overexpression of Bcl-xL in human breast cancer cells enhances organ-selective lymph node metastasis. España L, Fernández Y, Rubio N, Torregrosa A, Blanco J, Sierra A. Breast Cancer Res Treat; 2004 Sep; 87(1):33-44. PubMed ID: 15377849 [Abstract] [Full Text] [Related]
3. Inhibition of apoptosis in human breast cancer cells: role in tumor progression to the metastatic state. Fernández Y, Gu B, Martínez A, Torregrosa A, Sierra A. Int J Cancer; 2002 Oct 01; 101(4):317-26. PubMed ID: 12209955 [Abstract] [Full Text] [Related]
4. Organ-selective chemoresistance in metastasis from human breast cancer cells: inhibition of apoptosis, genetic variability and microenvironment at the metastatic focus. Gu B, España L, Méndez O, Torregrosa A, Sierra A. Carcinogenesis; 2004 Dec 01; 25(12):2293-301. PubMed ID: 15347599 [Abstract] [Full Text] [Related]
5. Bcl-x(L)-mediated changes in metabolic pathways of breast cancer cells: from survival in the blood stream to organ-specific metastasis. España L, Martín B, Aragüés R, Chiva C, Oliva B, Andreu D, Sierra A. Am J Pathol; 2005 Oct 01; 167(4):1125-37. PubMed ID: 16192647 [Abstract] [Full Text] [Related]
6. Bcl-xL promotes metastasis of breast cancer cells by induction of cytokines resistance. Fernández Y, España L, Mañas S, Fabra A, Sierra A. Cell Death Differ; 2000 Apr 01; 7(4):350-9. PubMed ID: 10773819 [Abstract] [Full Text] [Related]
7. Anti-apoptotic proteins induce non-random genetic alterations that result in selecting breast cancer metastatic cells. Méndez O, Fernández Y, Peinado MA, Moreno V, Sierra A. Clin Exp Metastasis; 2005 Apr 01; 22(4):297-307. PubMed ID: 16170666 [Abstract] [Full Text] [Related]
8. Bioluminescent human breast cancer cell lines that permit rapid and sensitive in vivo detection of mammary tumors and multiple metastases in immune deficient mice. Jenkins DE, Hornig YS, Oei Y, Dusich J, Purchio T. Breast Cancer Res; 2005 Apr 01; 7(4):R444-54. PubMed ID: 15987449 [Abstract] [Full Text] [Related]
9. A bcl-x(S) adenovirus demonstrates therapeutic efficacy in an ascites model of human breast cancer. Sumantran VN, Lee DS, Baker VV, Murray S, Strawderman M, Wicha MS. J Soc Gynecol Investig; 2000 Apr 01; 7(3):184-9. PubMed ID: 10865187 [Abstract] [Full Text] [Related]
10. Overexpression of BCL-x protein in primary breast cancer is associated with high tumor grade and nodal metastases. Olopade OI, Adeyanju MO, Safa AR, Hagos F, Mick R, Thompson CB, Recant WM. Cancer J Sci Am; 1997 Apr 01; 3(4):230-7. PubMed ID: 9263629 [Abstract] [Full Text] [Related]
11. Bcl-2 overexpression enhances the metastatic potential of a human breast cancer line. Del Bufalo D, Biroccio A, Leonetti C, Zupi G. FASEB J; 1997 Oct 01; 11(12):947-53. PubMed ID: 9337147 [Abstract] [Full Text] [Related]
12. Targeted therapy against Bcl-2-related proteins in breast cancer cells. Emi M, Kim R, Tanabe K, Uchida Y, Toge T. Breast Cancer Res; 2005 Oct 01; 7(6):R940-52. PubMed ID: 16280040 [Abstract] [Full Text] [Related]
13. Overexpression of the c-erbB-2 gene enhanced intrinsic metastasis potential in human breast cancer cells without increasing their transformation abilities. Tan M, Yao J, Yu D. Cancer Res; 1997 Mar 15; 57(6):1199-205. PubMed ID: 9067293 [Abstract] [Full Text] [Related]
14. [Establishment of a bioluminescent MDA-MB-231 cell line for in vivo imaging of human triple-negative breast cancer xenograft]. Wang K, Xie SM, He JJ, Ren Y, Xia HB, Zhang XW. Nan Fang Yi Ke Da Xue Xue Bao; 2011 Nov 15; 31(11):1812-8. PubMed ID: 22126756 [Abstract] [Full Text] [Related]
15. Angiopoietin-2, an angiogenic regulator, promotes initial growth and survival of breast cancer metastases to the lung through the integrin-linked kinase (ILK)-AKT-B cell lymphoma 2 (Bcl-2) pathway. Imanishi Y, Hu B, Xiao G, Yao X, Cheng SY. J Biol Chem; 2011 Aug 19; 286(33):29249-29260. PubMed ID: 21680733 [Abstract] [Full Text] [Related]
16. Metastatic burden in nude mice organs measured using prostate tumor PC-3 cells expressing the luciferase gene as a quantifiable tumor cell marker. Rubio N, Villacampa MM, El Hilali N, Blanco J. Prostate; 2000 Jul 01; 44(2):133-43. PubMed ID: 10881023 [Abstract] [Full Text] [Related]
17. Suberoylanilide hydroxamic acid (Zolinza/vorinostat) sensitizes TRAIL-resistant breast cancer cells orthotopically implanted in BALB/c nude mice. Shankar S, Davis R, Singh KP, Kurzrock R, Ross DD, Srivastava RK. Mol Cancer Ther; 2009 Jun 01; 8(6):1596-605. PubMed ID: 19509267 [Abstract] [Full Text] [Related]
18. Role of laminin in ovarian cancer tumor growth and metastasis via regulation of Mdm2 and Bcl-2 expression. Yoshida Y, Hosokawa K, Dantes A, Kotsuji F, Kleinman HK, Amsterdam A. Int J Oncol; 2001 May 01; 18(5):913-21. PubMed ID: 11295035 [Abstract] [Full Text] [Related]
19. Bcl-2-mediated cell survival promotes metastasis of EpH4 betaMEKDD mammary epithelial cells. Pinkas J, Martin SS, Leder P. Mol Cancer Res; 2004 Oct 01; 2(10):551-6. PubMed ID: 15498929 [Abstract] [Full Text] [Related]
20. Insulin-like growth factor 1 receptor enhances invasion and induces resistance to apoptosis of colon cancer cells through the Akt/Bcl-x(L) pathway. Sekharam M, Zhao H, Sun M, Fang Q, Zhang Q, Yuan Z, Dan HC, Boulware D, Cheng JQ, Coppola D. Cancer Res; 2003 Nov 15; 63(22):7708-16. PubMed ID: 14633695 [Abstract] [Full Text] [Related] Page: [Next] [New Search]